Concussion is an inherently complex diagnosis. Dr. Chris Klenck of @UTKnoxville on why objective brain assessment matters in concussion care. Part 2 of 4. https://t.co/Mgle8I6YSc #concussion#returntoplay
Dr. Drew Linsley leads deep learning at BrainScope and is speaking at the Global Mission Summit in Dallas. Catch him on Oct 8 at 10 am CT with Michael Moe for "The Flourishing Future…AI Driving Thriving."
Details: https://t.co/sZnctWeMRD
Matt Adams joins Dr. Aziri, Prof. Mitchell, Dr. Varley & Dr. Sills at the London Sports Med Summit TBI panel (Oct 9). See how BrainScope's 10-minute point-of-care electrical brain assessments deliver objective data to expedite safe return-to-play. https://t.co/V0RN3IXq4n
Starting tomorrow: a four-part series with @UTKnoxville Head Team Physician Dr. Chris Klenck on athlete brain health and #concussion care. One short video a week. Follow along.
BrainScope CEO Matt Adams joins the TBI panel at the London Sports Medicine Summit (Oct 9). Learn how 10-min point-of-care electrical brain scans provide objective return-to-play data.
https://t.co/V0RN3IXq4n
Congratulations to BrainScope President Laurie Silver on being named AI Champion in Washington Business Journal’s 2026 Innovators in Healthcare awards. We are applying AI to EEG to provide objective information about brain health at the point of care. https://t.co/Dfr1dpX3D2
@TexasFootball and @Vol_Football share a priority beyond the score: player health. BrainScope gives medical teams another source of information when evaluating suspected concussions. We're proud these teams are helping move concussion assessment forward. https://t.co/YPSXzqpFha
🚨 Just Announced 🚨:
BrainScope CEO Matt Adams joins innovators at the Culture Shifting Deal-Making Summit in NYC, Sept 24. Matt will demonstrate BrainScope's AI-driven, objective point-of-care assessment tool. Investors are encouraged to connect via [email protected]
On World Alzheimer’s Day, we recognize the urgency and extraordinary progress underway. The ADDF is investing in bold science and helping accelerate a future in which combination therapies and precision medicine define how we diagnose and ultimately treat Alzheimer’s.
7.2M Americans live with Alzheimer's today. 13M by 2050. This #WorldAlzheimersDay, we're focused on getting ahead of that curve, our EEG platform can help identify risk years before symptoms show. https://t.co/oMVk3DDgzv #WorldAlzheimersMonth#BrainHealth
🚨 Just Announced 🚨:
BrainScope CEO Matt Adams joins innovators at the Culture Shifting Deal-Making Summit in NYC, Sept 24. Matt will demonstrate BrainScope's AI-driven, objective point-of-care assessment tool. Investors are encouraged to connect via [email protected]
Every #concussion story needs a hero. Ours works quietly, giving clinicians an FDA-cleared, objective EEG-based data point in minutes, so "how do you feel?" isn't the only tool they've got. National #ConcussionAwarenessDay is Sept. 18. https://t.co/oMVk3DCIJX #TBI
As a parent, coach and athlete: If you could get an objective point-of-care concussion assessment in under ten minutes, would you take the time? BrainScope delivers an objective score to help evaluate severity and track recovery. https://t.co/CrIKBUSfUV
The brain is the last vital organ without an objective, real-time measurement tool. On BioTalk, BrainScope CEO Matt Adams joins Rich Bendis to discuss our FDA-cleared AI/EEG platform: objective brain data in minutes, from TBI to Alzheimer's risk. 🎧 https://t.co/otqE9REFkv
BrainScope appoints David Wingate as VP of Sales, bringing 30+ years of medtech leadership to accelerate AI-enabled brain health adoption. https://t.co/6fAe94nXAT #brainhealth#TBI#concussion#alzheimers#EEG
New peer-reviewed study in Scientific Reports (Nature Portfolio): BrainScope’s latest EEG biomarker predicted cognitive decline up to 7 years before diagnosis with strong accuracy.